Stock-Based Compensation | 5. Stock-Based Compensation The compensation costs that have been charged against income for the thirteen and twenty-six weeks ended July 29, 2017 and July 30, 2016 were as follows (in thousands): Thirteen Weeks Ended Twenty-Six Weeks Ended July 29, 2017 July 30, 2016 July 29, 2017 July 30, 2016 Stock-based compensation expense by type: Stock options $ - $ 3 $ 172 $ 384 Restricted stock unit awards, including performance-based 618 898 2,109 2,607 Employee stock purchases 23 22 56 58 Director deferred compensation 6 24 12 47 Total stock-based compensation expense 647 947 2,349 3,096 Income tax benefit recognized 228 344 844 1,125 Stock-based compensation expense, net of income tax $ 419 $ 603 $ 1,505 $ 1,971 In the thirteen and twenty-six weeks ended July 29, 2017 and July 30, 2016, we granted the following equity awards: Thirteen Weeks Ended Twenty-Six Weeks Ended July 29, 2017 July 30, 2016 July 29, 2017 July 30, 2016 Stock options - 318 20,372 36,359 Restricted stock unit awards - - 108,429 100,775 Performance-based restricted stock unit awards - - 54,900 45,300 Deferred stock units 286 674 487 14,156 At July 29, 2017, the total compensation costs related to nonvested restricted stock unit awards not yet recognized was $7.3 million and the weighted-average period over which such awards are expected to be recognized was 2.6 years. There are no future compensation costs related to nonvested stock options to be recognized at July 29, 2017. Under the 2012 Non-Employee Director Equity Plan (2012 Plan), a total of 3,361 and 2,851 shares of our common stock were awarded during the thirteen and twenty-six weeks ended July 29, 2017 and July 30, 2016, respectively, as part of the annual equity award to directors in the first quarter. The weighted-average grant date fair value of stock options granted during the thirteen and twenty-six weeks ended July 29, 2017 was $8.47 per share. The weighted-average grant date fair value of stock options granted during the thirteen and twenty-six weeks ended July 30, 2016 was $9.88 and $10.56 per share, respectively. Our employee purchases of common stock, the average price per share and the weighted-average grant date fair value of shares purchased through the our employee stock purchase plan were as follow: Thirteen Weeks Ended Thirty-Nine Weeks Ended July 29, 2017 July 30, 2016 July 29, 2017 July 30, 2016 Shares purchased 5,281 3,021 10,745 8,638 Average price per share $ 17.64 $ 29.57 $ 21.42 $ 27.05 Weighted average fair value at grant date $ 6.26 $ 7.49 $ 5.24 $ 6.83 |